Pao William 4

What Happened William Pao, a director of Immunocore Holdings plc (IMCR), was granted a derivative equity award covering 27,492 shares on May 27, 2026. The Form 4 reports the acquisition price as $0.00 and lists the award as a derivative security (transaction code A), indicating a compensatory grant rather than an open-market purchase.

Key Details

• Transaction date: 2026-05-27; Form 4 filed 2026-05-28 (appears timely).
• Security/amount: 27,492 shares (derivative award) reported at $0.00 acquisition price.
• Shares owned after transaction: Not specified in the filing.
• Footnote (vesting): The award vests at the earlier of (i) May 27, 2027 or (ii) the day before the issuer’s next annual general meeting, subject to continuous service through vesting.
• Transaction code: A = Award/Grant (compensatory). No 10b5-1, tax withholding, or sale noted.

Context This filing documents a compensation award (not a market purchase or sale). Such grants are common for directors as part of incentive compensation and do not by themselves indicate buying or selling intent. The derivative nature and the vesting condition mean the shares are subject to forfeiture until vesting; additional filings may follow if options are exercised or shares are issued.